G&F Medical Inc is categorized under Silicone Rubbers in Danvers, MA and active since 2007.
G&F Medical Inc was established in 2007, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Silicone Rubbers business, which does work in the B2B market, and is classified as a Silicone Rubbers, under code number 3262991 by the NAICS.
If you are seeking more information, feel free to contact John Argitis, Chief Executive Officer at the company’s single location by writing to 33 Cherry Hill Drive # 2, Danvers, Massachusetts MA 01923 or by phoning (978) 560-2619. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | G&F Medical Inc |
Contact Person: | John Argitis, Chief Executive Officer |
Address: | 33 Cherry Hill Drive # 2, Danvers, Massachusetts 01923 |
Phone Number: | (978) 560-2619 |
Website Address: | gandfmedical.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Silicone Rubbers |
SIC Code: | 2822 |
NAICS Code: | 3262991 |
Share This Business: |
G&F Medical Inc was started in 2007 to provide professional Silicone Rubbers under the SIC code 2822 and NAICS code 3262991. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact John Argitis, Chief Executive Officer for inquiries that concern G&F Medical Inc by calling the company number (978) 560-2619, as your correspondence is most welcome. Additionally, the physical location of the single location of G&F Medical Inc can be found at the coordinates 42.57937,-70.91462 as well as the street address 33 Cherry Hill Drive # 2 in Danvers, Massachusetts 01923.
For its online presence, you may visit G&F Medical Inc’s website at gandfmedical.com and engage with its social media outlets through on Twitter and on Facebook.